GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $21,000 | +10.5% | 504 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $19,000 | -9.5% | 504 | 0.0% | 0.01% | -11.1% |
| Q3 2018 | $21,000 | +5.0% | 504 | 0.0% | 0.01% | +12.5% |
| Q2 2018 | $20,000 | -57.4% | 504 | -58.1% | 0.01% | -52.9% |
| Q1 2018 | $47,000 | +14.6% | 1,204 | +4.3% | 0.02% | +13.3% |
| Q4 2017 | $41,000 | -81.1% | 1,154 | -78.4% | 0.02% | -82.1% |
| Q3 2017 | $217,000 | -0.5% | 5,338 | +5.7% | 0.08% | -7.7% |
| Q2 2017 | $218,000 | -42.0% | 5,052 | -43.4% | 0.09% | -44.2% |
| Q1 2017 | $376,000 | +4.2% | 8,919 | -5.0% | 0.16% | -1.8% |
| Q4 2016 | $361,000 | -22.4% | 9,386 | -12.9% | 0.17% | -23.1% |
| Q3 2016 | $465,000 | +102.2% | 10,775 | +103.8% | 0.22% | +94.6% |
| Q2 2016 | $230,000 | -71.8% | 5,286 | -73.8% | 0.11% | -71.7% |
| Q1 2016 | $816,000 | +2.8% | 20,147 | +2.4% | 0.39% | +10.7% |
| Q4 2015 | $794,000 | – | 19,684 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |